Executive Vice President and Head of Sanofi Genzym
oncology
Sanofi Genzyme
Ireland
Bill Sibold is Executive Vice President and Head of Sanofi Genzyme, the specialty care global business unit of Sanofi. In this role, he is a member of the Sanofi Executive Committee.Bill has more than 25 years of experience in the biopharmaceutical industry since starting his career with Eli Lilly. He held a number of leadership positions at Biogen, including driving their U.S. commercial operations in neurology, oncology and rheumatology, and general management of Biogen’s Australian and Asia-Pacific business. In addition to his time with Biogen, Bill also served as Chief Commercial Officer of Avanir Pharmaceuticals.
New immunology treatments, Multiple sclerosis, oncology research